Literature DB >> 1656093

Human herpesvirus 7: antigenic properties and prevalence in children and adults.

L S Wyatt1, W J Rodriguez, N Balachandran, N Frenkel.   

Abstract

The recent isolation of human herpesvirus 7 (HHV-7) from activated CD4+ T lymphocytes of a healthy individual raises questions regarding the prevalence of this virus in humans and its immunological relationship to previously characterized human herpesviruses. We report that HHV-7 is a ubiquitous virus which is immunologically distinct from the highly prevalent T-lymphotropic HHV-6. Thus, (i) only two of six monoclonal antibodies to HHV-6 cross-reacted with HHV-7-infected cells, (ii) Western immunoblot analyses of viral proteins revealed different patterns for HHV-6- and HHV-7-infected cells, (iii) tests of sequential serum samples from children revealed seroconversion to HHV-6 without concomitant seroconversion to HHV-7, and (iv) in some instances HHV-7 infection occurred in the presence of high titers of HHV-6 antibodies, suggesting the lack of apparent protection of children seropositive for HHV-6 against subsequent infection with HHV-7. On the basis of the analyses of sera from children and adults it can be concluded that HHV-7 is a prevalent human herpesvirus which, like other human herpesviruses, infects during childhood. The age of infection appears to be somewhat later than the very early age documented for HHV-6.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656093      PMCID: PMC250327     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Characteristics of human herpesvirus-6.

Authors:  C Lopez; P Pellett; J Stewart; C Goldsmith; K Sanderlin; J Black; D Warfield; P Feorino
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

2.  Exanthem subitum and antibody to human herpesvirus-6.

Authors:  K Ueda; K Kusuhara; M Hirose; K Okada; C Miyazaki; K Tokugawa; M Nakayama; K Yamanishi
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

3.  Age prevalence of antibody to human herpesvirus 6.

Authors:  M Briggs; J Fox; R S Tedder
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

4.  A novel lymphotropic herpesvirus.

Authors:  R S Tedder; M Briggs; C H Cameron; R Honess; D Robertson; H Whittle
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

5.  Isolation of human lymphotropic herpesviruses from Uganda.

Authors:  R G Downing; N Sewankambo; D Serwadda; R Honess; D Crawford; R Jarrett; B E Griffin
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

6.  Variations in the replication and antigenic properties of human herpesvirus 6 strains.

Authors:  L S Wyatt; N Balachandran; N Frenkel
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

7.  Prevalence of antibody to human herpesvirus 6 in women and children.

Authors:  K Balachandra; P I Ayuthaya; W Auwanit; C Jayavasu; T Okuno; K Yamanishi; M Takahashi
Journal:  Microbiol Immunol       Date:  1989       Impact factor: 1.955

8.  Seroepidemiology of human herpesvirus 6 infection in normal children and adults.

Authors:  T Okuno; K Takahashi; K Balachandra; K Shiraki; K Yamanishi; M Takahashi; K Baba
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

9.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.

Authors:  J A Levy; F Ferro; D Greenspan; E T Lennette
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

View more
  48 in total

1.  The 85-kilodalton phosphoprotein (pp85) of human herpesvirus 7 is encoded by open reading frame U14 and localizes to a tegument substructure in virion particles.

Authors:  A Stefan; P Secchiero; T Baechi; W Kempf; G Campadelli-Fiume
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction.

Authors:  D A Clark; I M Kidd; K E Collingham; M Tarlow; T Ayeni; A Riordan; P D Griffiths; V C Emery; D Pillay
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 4.  Herpesvirus infections in organ transplant recipients.

Authors:  Frank J Jenkins; David T Rowe; Charles R Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

5.  And then there were eight...

Authors:  S D Shafran; J M Conly
Journal:  Can J Infect Dis       Date:  1996-01

6.  Disease association and diagnosis of human herpesvirus 6.

Authors:  J Weber; G Wilson
Journal:  Can J Infect Dis       Date:  1994-07

7.  CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B.

Authors:  W Kempf; V Adams; N Wey; R Moos; M Schmid; E Avitabile; G Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

8.  Clinical manifestations associated with human herpesvirus 7 infection.

Authors:  S Torigoe; T Kumamoto; W Koide; K Taya; K Yamanishi
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

9.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus.

Authors:  Z N Berneman; D V Ablashi; G Li; M Eger-Fletcher; M S Reitz; C L Hung; I Brus; A L Komaroff; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.